Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Congenital Abnormalities 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Multiple Myeloma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, Mantle-Cell 6Leukemia 6Sezary Syndrome 5Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Mycosis Fungoides 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Lung Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Blast Crisis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Leukemia, Myeloid, Chronic-Phase 3

Interventions

Mycophenolic Acid 25fludarabine phosphate 21Whole-Body Irradiation 21Cyclophosphamide 21Cyclosporine 16Tacrolimus 15Peripheral Blood Stem Cell Transplantation 15Busulfan 14fludarabine 11Cord Blood Stem Cell Transplantation 9Methotrexate 8Melphalan 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8Antilymphocyte Serum 8Filgrastim 7Thiotepa 6Etoposide 6sargramostim 4merphos 4Radiotherapy 4Drug Therapy 4Cyclosporins 4Azacitidine 4thymoglobulin 3Vorinostat 3Sirolimus 3Lenalidomide 3Idarubicin 3tipifarnib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Anemia, Refractory, with Excess of Blasts × Flow Cytometry × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

NCT00425477 2018-10-05

Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
26 enrolled 7 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡